Lisa Hicks

MD, MSc

Investigator

Biography

Dr. Lisa Hicks is a malignant hematologist at St. Michael’s Hospital with an academic focus on quality improvement and innovation. She uses traditional clinical epidemiology methods combined with quality improvement techniques to develop interventions to improve the safety and efficiency of patient care. Thematically, her work focuses on understanding drivers of over-utilization in healthcare and on developing strategies to decrease this phenomenon. She also has an interest in understanding and preventing harm from cancer treatments. In particular, Dr. Hicks leads research that aims to understand the risk of Hepatitis B Virus (HBV) reactivation in cancer patients and to explore how this risk is understood, communicated and managed by clinicians. Dr. Hicks is also an active contributor to the development of clinical practice guidelines. She collaborates in this work with Cancer Care Ontario (CCO) and the American Society of Hematology (ASH). Finally, Dr. Hicks has a large clinical practice in Human Immunodeficiency Virus (HIV) associated lymphoma and has led clinical studies in this area.

Dr. Hicks is the Chair of the Committee on Quality, for the American Society of Hematology (ASH) and is past-chair of the ASH Choosing Wisely Task Force. Dr. Hicks is the St. Michael’s Hospital Lead for a Hospital initiative addressing overutilization. Finally, she is an active member of the CCO Hematology Disease Site Group and has been an expert contributor to the pan Canadian Oncology Drug Review process.

Recent Publications

  1. Mohammed-Ali, Z, Bhandarkar, S, Tahir, S, Handford, C, Yip, D, Beriault, D et al.. Implementing effective test utilization via team-based evaluation and revision of a family medicine laboratory test requisition. BMJ Open Qual. 2021;10 (1):. doi: 10.1136/bmjoq-2020-001219. PubMed PMID:33731485 PubMed Central PMC7978073.
  2. Beriault, DR, Gilmour, JA, Hicks, LK. Overutilization in laboratory medicine: tackling the problem with quality improvement science. Crit Rev Clin Lab Sci. 2021; :1-24. doi: 10.1080/10408363.2021.1893642. PubMed PMID:33691585 .
  3. Lyman, GH, Carrier, M, Ay, C, Di Nisio, M, Hicks, LK, Khorana, AA et al.. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5 (4):927-974. doi: 10.1182/bloodadvances.2020003442. PubMed PMID:33570602 PubMed Central PMC7903232.
  4. Bodley, T, Chan, M, Levi, O, Clarfield, L, Yip, D, Smith, O et al.. Patient harm associated with serial phlebotomy and blood waste in the intensive care unit: A retrospective cohort study. PLoS One. 2021;16 (1):e0243782. doi: 10.1371/journal.pone.0243782. PubMed PMID:33439871 PubMed Central PMC7806151.
  5. Wood, WA, Neuberg, DS, Thompson, JC, Tallman, MS, Sekeres, MA, Sehn, LH et al.. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. Blood Adv. 2020;4 (23):5966-5975. doi: 10.1182/bloodadvances.2020003170. PubMed PMID:33278301 PubMed Central PMC7724912.
  6. Vijenthira, A, Gong, IY, Fox, TA, Booth, S, Cook, G, Fattizzo, B et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136 (25):2881-2892. doi: 10.1182/blood.2020008824. PubMed PMID:33113551 PubMed Central PMC7746126.
  7. May, JE, Irelan, PC, Boedeker, K, Cahill, E, Fein, S, Garcia, DA et al.. Systems-based hematology: highlighting successes and next steps. Blood Adv. 2020;4 (18):4574-4583. doi: 10.1182/bloodadvances.2020002947. PubMed PMID:32960959 PubMed Central PMC7509880.
  8. Taher, J, Beriault, DR, Yip, D, Tahir, S, Hicks, LK, Gilmour, JA et al.. Reducing free thyroid hormone testing through multiple Plan-Do-Study-Act cycles. Clin Biochem. 2020;81 :41-46. doi: 10.1016/j.clinbiochem.2020.05.004. PubMed PMID:32416171 .
  9. Izcovich, A, Cuker, A, Kunkle, R, Neumann, I, Panepinto, J, Pai, M et al.. A user guide to the American Society of Hematology clinical practice guidelines. Blood Adv. 2020;4 (9):2095-2110. doi: 10.1182/bloodadvances.2020001755. PubMed PMID:32396622 PubMed Central PMC7218428.
  10. Chan, M, Silverstein, WK, Nikonova, A, Pavenski, K, Hicks, LK. Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature. Blood Adv. 2020;4 (8):1756-1759. doi: 10.1182/bloodadvances.2020001726. PubMed PMID:32343794 PubMed Central PMC7189296.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Department of Medicine, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto
X